“Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer”

“Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer”

Abstract Background ROS1 fusion is an infrequent, but attractive target for therapy in patients with metastatic non- small-cell lung cancer. In studies on mainly late-stage disease, the prevalence of ROS1 fusions is about 1–3%. In early-stage lung cancer ROS1 might also provide a fruitful target for...

Full description

Bibliographic Details
Main Authors: Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, Marianne Odnakk Ludahl, Joakim Oliu Moe, Inger Johanne Zwicky Eide, Marius Lund-Iversen, Odd Terje Brustugun
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Diagnostic Pathology
Subjects:
Lung cancer
ROS1
Targeted therapy
NGS
Immunohistochemistry
Online Access:https://doi.org/10.1186/s13000-023-01357-1

Internet

https://doi.org/10.1186/s13000-023-01357-1

Similar Items